Heart Test Valuation
| HSCS Stock | USD 3.18 0.02 0.63% |
At this time, the firm appears to be undervalued. Heart Test Laboratories retains a regular Real Value of $4.88 per share. The prevalent price of the firm is $3.18. Our model calculates the value of Heart Test Laboratories from evaluating the firm fundamentals such as return on asset of -0.75, and Return On Equity of -2.2 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Heart Test's valuation include:
Price Book 2.417 | Enterprise Value | Enterprise Value Ebitda (0.14) | Price Sales 1.2 K | Enterprise Value Revenue 1 K |
Undervalued
Today
Please note that Heart Test's price fluctuation is unstable at this time. Calculation of the real value of Heart Test Laboratories is based on 3 months time horizon. Increasing Heart Test's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Heart stock is determined by what a typical buyer is willing to pay for full or partial control of Heart Test Laboratories. Since Heart Test is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Heart Stock. However, Heart Test's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.18 | Real 4.88 | Target 10.6 | Hype 3.18 | Naive 3.05 |
The intrinsic value of Heart Test's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Heart Test's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Heart Test Laboratories helps investors to forecast how Heart stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heart Test more accurately as focusing exclusively on Heart Test's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Heart Test's intrinsic value based on its ongoing forecasts of Heart Test's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Heart Test's closest peers.
Heart Test Cash |
|
Heart Test Total Value Analysis
Heart Test Laboratories is currently forecasted to have valuation of 9.1 M with market capitalization of 10.11 M, debt of 2.99 M, and cash on hands of 4.27 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Heart Test fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.1 M | 10.11 M | 2.99 M | 4.27 M |
Heart Test Investor Information
The book value of the company was currently reported as 1.36. The company recorded a loss per share of 6.56. Heart Test Laboratories had not issued any dividends in recent years. The entity had 1:100 split on the . Based on the key indicators related to Heart Test's liquidity, profitability, solvency, and operating efficiency, Heart Test Laboratories is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Heart Test Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Heart Test has an asset utilization ratio of 0.1 percent. This implies that the Company is making $0.00103 for each dollar of assets. An increasing asset utilization means that Heart Test Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Heart Test Profitability Analysis
Based on Heart Test's profitability indicators, Heart Test Laboratories may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Heart Test's ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -7.9 M | Current Value -8.3 M | Quarterly Volatility 1.9 M |
For Heart Test profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Heart Test Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Heart Test utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Heart Test's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Heart Test over time as well as its relative position and ranking within its peers.
Heart Test Earnings per Share Projection vs Actual
The next projected EPS of Heart Test is estimated to be -0.88 with future projections ranging from a low of -0.92 to a high of -0.84. Heart Test's most recent 12-month trailing earnings per share (EPS TTM) is at -6.56. Please be aware that the consensus of earnings estimates for Heart Test Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.Heart Test Earnings Estimation Breakdown
The calculation of Heart Test's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Heart Test is estimated to be -0.88 with the future projection ranging from a low of -0.92 to a high of -0.84. Please be aware that this consensus of annual earnings estimates for Heart Test Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.92 Lowest | Expected EPS | -0.84 Highest |
Heart Test Earnings Projection Consensus
Suppose the current estimates of Heart Test's value are higher than the current market price of the Heart Test stock. In this case, investors may conclude that Heart Test is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Heart Test's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of January 2026 | Current EPS (TTM) | |
| 2 | 51.64% | -0.85 | -0.88 | -6.56 |
Heart Test Ownership Allocation
The market capitalization of Heart Test is $10.11 Million. Heart Test retains 5.12 (percent) of its outstanding shares held by insiders and 5.7 (percent) owned by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Heart Test Profitability Analysis
The company reported the previous year's revenue of 4.35 K. Net Loss for the year was (8.77 M) with profit before overhead, payroll, taxes, and interest of 5.02 K.About Heart Test Valuation
The stock valuation mechanism determines Heart Test's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Heart Test Laboratories based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Heart Test. We calculate exposure to Heart Test's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Heart Test's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -112.9 K | -107.3 K | |
| Pretax Profit Margin | -2.3 K | -2.2 K | |
| Operating Profit Margin | -2.2 K | -2.1 K | |
| Net Loss | -2.3 K | -2.2 K | |
| Gross Profit Margin | (33.17) | (31.52) |
Heart Test Current Valuation Indicators
Heart Test's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Heart Test's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Heart Test, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Heart Test's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Heart Test's worth.Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.